Comparison of Biportal Versus Multiportal Robotic Approaches for Pulmonary Resection in NSCLC
EC-UMUR
Clinical Trial in Patients With Non-Small Cell Lung Cancer Undergoing Biportal Versus Multiportal Robotic Thoracic Surgery: Comparison of Two Innovative Techniques
1 other identifier
interventional
80
1 country
1
Brief Summary
This study compares two established robotic surgical approaches for removing lung tumors in adults with non-small cell lung cancer: biportal robotic-assisted thoracic surgery (biRATS) and multiportal robotic-assisted thoracic surgery (multiRATS). Participants are assigned at random to one of the two approaches. The study will compare surgical safety, recovery after surgery, pain, length of hospital stay, quality of life, and other clinical outcomes during 12 months of follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable nonsmall-cell-lung-cancer
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2026
CompletedFirst Submitted
Initial submission to the registry
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
September 14, 2026
September 1, 2026
2 years
September 1, 2026
September 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Intraoperative and Immediate Postoperative Complications
Proportion of participants with intraoperative or immediate postoperative complications, classified by Clavien-Dindo grade. Events include, among others, prolonged air leak, pleuropulmonary infection, pneumothorax, postoperative hemorrhage, chylothorax, respiratory failure, wound infection, readmission, and perioperative death.
From surgery through hospital discharge, up to 30 days
Secondary Outcomes (8)
Intraoperative Blood Loss
During surgery
Length of Hospital Stay
From surgery through hospital discharge, up to 30 days
Postoperative Pain Intensity (Visual Analog Scale)
From baseline through 12 months after surgery
Neuropathic Pain (Douleur Neuropathique 4 Questionnaire)
From baseline through 12 months after surgery
Health Status (EuroQol 5-Dimension 5-Level Questionnaire)
From baseline through 12 months after surgery
- +3 more secondary outcomes
Study Arms (2)
biRATS
EXPERIMENTALBiportal robotic-assisted thoracic surgery for pulmonary resection using two access incisions.
multiRATS
ACTIVE COMPARATORMultiportal robotic-assisted thoracic surgery for pulmonary resection using multiple access ports.
Interventions
Pulmonary resection performed with a biportal robotic-assisted thoracic surgery approach using two access incisions.
Pulmonary resection performed with a multiportal robotic-assisted thoracic surgery approach using multiple access ports.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older, of any sex.
- Non-small cell lung cancer considered clinically resectable, confirmed preoperatively or during surgery.
- Candidate for pulmonary resection by robotic thoracic surgery.
- Written informed consent.
You may not qualify if:
- Declines participation or cannot provide written informed consent.
- Thoracic anatomical abnormalities that preclude or materially affect robotic surgery.
- Active thoracic infection.
- Surgery not performed by a participating surgeon with comparable experience in biRATS and multiRATS.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Carlos Dénizlead
Study Sites (1)
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carlos Déniz Armengol, MD, PhD
Hospital Universitari de Bellvitge
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants are partially masked to the allocated surgical approach by standardized dressings maintained for 48 hours after surgery.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Thoracic Surgeon
Study Record Dates
First Submitted
September 1, 2026
First Posted
September 14, 2026
Study Start
January 15, 2026
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2028
Last Updated
September 14, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because of data-protection and institutional-governance requirements.